Form 4 for EHC Encompass Health Corp
Accepted 2022-02-28 00:00:00 ET · period of report 2022-02-24 · accession 0001127602-22-006970 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-02-28 | 2022-02-25 | EHC | Tarr Mark J | Pres, CEO, Dir | A - Grant | $0.00 | +48.0K | 428.6K | +13% | $0 |
| 2022-02-28 | 2022-02-24 | EHC | Tarr Mark J | Pres, CEO, Dir | F - Tax | $65.52 | -1,873 | 380.6K | -0.5% | -$122.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Encompass Health Common Stock | 2022-02-25 | A | A | 16,258 | $0.00 | 396,827 | D | — | — | (F2) Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. |
| 2 | Common | Encompass Health Common Stock | 2022-02-24 | F | D | 1,873 | $65.52 | 380,569 | D | — | — | (F1) These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. |
| 3 | Common | Encompass Health Common Stock | 2022-02-25 | A | A | 31,730 | $0.00 | 428,557 | D | — | — | (F3) This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 20, 2020. |